Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06266611 · ClinicalTrials.gov registry record · Phase 2

Cannabis for Palliative Care in Cancer

A Phase 2 study of Depression and Pain, sponsored by University of Colorado, Boulder.

Recruiting
Registry status
Phase 2
Development phase
185
Enrollment target
1
Study location

NCT06266611 is a Phase 2 study of Depression and Pain that is actively recruiting participants, run by University of Colorado, Boulder. The registered enrollment target is 185 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06266611, a Phase 2 study of Depression and Pain, is actively recruiting participants, sponsored by University of Colorado, Boulder.

RECRUITING
Registry status
Phase 2
Development phase
185 participants
Enrollment target
1
Study location

Study Summary

Many cancer patients suffer from pain, sleep, and mood problems and are using cannabis to relieve these symptoms. Cannabis may provide such relief but may also produce negative side effects including cognitive impairment, an especially problematic issue for cancer patients, indicating more research on cannabis use in the cancer context is required. In this endeavor, the present study seeks to compare the use of hemp-derived CBD (Cannabidiol) with and without THC (Delta-9-tetrahydrocannabinol) versus placebo on measures of sleep, pain, mood, subjective and objective cognitive functioning, and quality of life within 185 cancer patients.

Conditions Studied

Depression Pain Anxiety Sleep

Interventions

  • DRUG Placebo
  • DRUG fsCBD Cannabidiol
  • DRUG bsCBD Cannabidiol

Study Locations (1)

Colorado

  • Anschutz Health Sciences Building - Aurora

Trial Details

FieldValue
Enrollment Target 185 participants
Start Date 2024-09-16
Est. Completion 2028-06-30
Phase Phase 2

Sponsor

University of Colorado, Boulder

69 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06266611

The ClinicalTrials.gov registry entry for NCT06266611 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 185 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (76% lower). The listed sponsor is University of Colorado, Boulder, which has 69 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT06266611 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT06266611 about?

NCT06266611 is a clinical study titled "Cannabis for Palliative Care in Cancer". Many cancer patients suffer from pain, sleep, and mood problems and are using cannabis to relieve these symptoms. Cannabis may provide such relief but may also produce negative side effects including cognitive impairment, an especially problematic issue for cancer patients, indicating more research ...

What is the current status of trial NCT06266611?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 185 participants. The study started on 2024-09-16. Estimated completion is 2028-06-30.

What conditions does trial NCT06266611 study?

This clinical trial studies the following conditions: Depression, Pain, Anxiety, Sleep.

What interventions are being tested in trial NCT06266611?

The interventions under investigation include: Placebo (DRUG), fsCBD Cannabidiol (DRUG), bsCBD Cannabidiol (DRUG).

Who is sponsoring clinical trial NCT06266611?

This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06266611 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Depression

All registered trials for this condition

Pain

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.